The Depo-Provera meningioma lawsuit.
Research has linked long-term use of medroxyprogesterone acetate — the active ingredient in Depo-Provera — to a significantly increased risk of intracranial meningioma. Cases are now consolidated in federal court. If you or a loved one were affected, you may be able to request a case review.
Lawsuit Center is not a law firm and does not provide legal advice. Submitting information does not guarantee eligibility, compensation, contact, or representation.
What the Depo-Provera lawsuit is about.
A 2024 study published in The BMJ (Roland et al.) reported that women who used medroxyprogesterone acetate for approximately one year or longer faced a meningioma risk roughly five times higher than non-users. Plaintiffs in the Depo-Provera litigation allege that Pfizer knew — or should have known — about this risk and failed to adequately warn patients and prescribing physicians.
The cases have been consolidated as multidistrict litigation (MDL 3140) in the U.S. District Court for the Northern District of Florida. An MDL is not a class action: each plaintiff retains an individual case, but pretrial proceedings are coordinated before a single judge for efficiency.
Situations that often fit the claim pattern.
Eligibility for a Depo-Provera meningioma claim depends on duration of use, timing of diagnosis, and the laws of your state. The following situations are the ones most often reviewed:
- Used Depo-Provera (or generic medroxyprogesterone acetate) for approximately one year or longer and later diagnosed with a meningioma
- Used Depo-SubQ Provera 104 long-term and later diagnosed with an intracranial or spinal meningioma
- Underwent surgery, radiation, or ongoing monitoring for a meningioma after Depo-Provera use
- Diagnosed with multiple meningiomas after long-term Depo-Provera or MPA use
- A loved one was diagnosed with a meningioma after years of Depo-Provera injections
Damages that may be recovered.
The value of any individual claim depends on the severity of the injury, the duration of Depo-Provera use, and the laws of your state. No outcome is guaranteed. Speak with a licensed attorney as soon as possible — statutes of limitations vary and may be short.
Medical expenses
Surgery, radiation, hospitalization, and ongoing or future treatment costs.
Lost income
Wages lost during treatment and any reduced future earning capacity.
Pain & suffering
Physical pain, emotional distress, and reduced quality of life.
Loss of consortium
Damages that may be available to a spouse for impact on the marital relationship.
Reviewing this category of claim.
Case review submissions for Depo-Provera meningioma claims may be reviewed by the participating firm below. Sponsored visibility is advertising and is not a recommendation or endorsement by Lawsuit Center. Visitors should evaluate any law firm independently before choosing to hire counsel.
Depo-Provera lawsuit FAQ.
What is the Depo-Provera lawsuit about?
The Depo-Provera lawsuit centers on allegations that Pfizer, the maker of Depo-Provera (medroxyprogesterone acetate), failed to warn patients and physicians that long-term use of the contraceptive injection is associated with an increased risk of intracranial meningioma. The cases are consolidated in MDL 3140 in the Northern District of Florida.
Who may qualify for a Depo-Provera lawsuit?
Generally, individuals who used Depo-Provera or its generic equivalent (medroxyprogesterone acetate) for approximately one year or longer and were later diagnosed with an intracranial or spinal meningioma may potentially qualify. Eligibility depends on duration of use, timing of diagnosis, and the laws of the state where the claim is filed.
How long do I have to file a Depo-Provera claim?
Statutes of limitations vary by state and typically run from the date of diagnosis or the date the injury was reasonably connected to Depo-Provera. Some states also have statutes of repose or pharmaceutical immunity statutes that may affect claims. Because deadlines can be short, it is important to speak with a licensed attorney as soon as possible.
Is there a class action or an MDL?
The Depo-Provera cases have been consolidated as a multidistrict litigation (MDL 3140) in the U.S. District Court for the Northern District of Florida. An MDL is not the same as a class action — each plaintiff retains an individual case, but pretrial proceedings are coordinated before a single judge.
What compensation may be available?
Damages may include past and future medical expenses, surgery and treatment costs, lost wages and lost earning capacity, pain and suffering, and loss of consortium. The amount depends on the severity of the injury and the specific facts of each individual case. No outcome is guaranteed.
What if I'm not sure how long I used Depo-Provera?
Many individuals do not have a complete record of every injection. An attorney can help obtain pharmacy and medical records to establish the duration of use. You can submit a case review request and provide approximate dates.
Request a free Depo-Provera case review.
Tell us briefly about Depo-Provera use and any meningioma diagnosis. Your submission may be reviewed by participating legal professionals, legal advertisers, or intake partners where available. Submitting does not create an attorney-client relationship.
Created by a California-licensed attorney. A submission does not guarantee eligibility, compensation, contact, or representation.